Lotemax - Consumer Medicine Information
|Manufacture:||Bausch and Lomb|
|Condition:||Postoperative Ocular Inflammation|
|Form:||Eye drops (ophthalmic)|
|Ingredients:||loteprednol etabonate, benzalkonium chloride, edetate disodium, glycerin, povidone, purified water, tyloxapol|
About this Medication
What the Medication is Used for:
Lotemax is used for the treatment of post-operative inflammation of the eye following cataract surgery.
What it does:
Loteprednol etabonate is a corticosteriod. It acts by reducing inflammation and eases the symptoms.
When it should not be used:
Do not use Lotemax:
- If you are allergic to loteprednol or any ingredients contained in Lotemax (see What the nonmedicinal ingredients are), or if you are allergic to any other corticosteroid.
- If you have eye diseases caused by viruses such as herpes simplex, vaccinia, and varicella) or caused by bacteria or a fungus, or if you think you have any other eye infection.
- If you are pregnant, breastfeeding, under 18 years of age or have had glaucoma or increased pressure in the eye, see Warnings and Precautions.
What the Medicinal ingredient is:
The medicinal ingredient is loteprednol etabonate. Each mL contains 5 mg (0.5% w/v) loteprednol etabonate.
What the important nonmedicinal ingredients are:
Benzalkonium Chloride (0.01% w/v) as preservative
Edetate Disodium, Glycerin, Povidone, Purified Water and Tyloxapol. Hydrochloric Acid and/or Sodium Hydroxide may be added to adjust the pH.
What dosage forms it comes in:
Sterile ophthalmic suspension (eye drops) 0.5% w/v
Warnings and Precautions
BEFORE you use Lotemax talk to your doctor or pharmacist if:
- Lotemax should not be used if you are pregnant, breastfeeding or under 18 years of age.
- If you are pregnant or intend to become pregnant, or if you are breastfeeding as there might be a risk of harm to the embryo/foetus or nursing baby.
- If you have an eye disease/infection caused by viruses (such as herpes simplex, vaccinia, and varicella), or by bacteria or a fungus, or if you think you have any other eye infection.
- If you have glaucoma or have been told that you have increased pressure in the eye as Lotemax might increase the pressure in the eye. Glaucoma which occurs when the pressure in the eye increases for a period of time, can cause damage to the optic nerve, vision problems, and sometimes a loss of vision. Your doctor may monitor your intraocular pressure.
- If signs and symptoms fail to improve after two days of using Lotemax, consult your doctor.
Consult your doctor if the following occurs while taking Lotemax:
- If you develop an eye infection or other new or worsening symptoms.
The preservative in Lotemax, benzalkonium chloride, may be absorbed by soft contact lenses. After instilling Lotemax, you must wait at least 10 to 15 minutes before inserting your contact lenses. Do not wear a contact lens if your eye is red. Lotemax should not be used to treat contact lens irritation.
Interactions with this Medication
Drugs that may interact with Lotemax include: medicines taken to control the ocular pressure. Please inform your doctor or pharmacist if you are taking or have taken recently any other medicines, even those not prescribed.
Proper use of this Medication
This product is sterile when packaged.
For ophthalmic use only.
For Adults only.
Do not use in children, or if you are pregnant or breastfeeding.
- Shake Lotemax eye drops vigorously before using.
- Apply one drop of Lotemax eye drops into the gap between your eyeball and eyelid, four times a day or as directed.
- If applying more than one drop, wait 30 seconds before the second drop is applied to the eye.
- Do not allow the tip of the dropper to touch any surface because this may contaminate the medicine.
- If you wear soft contact lenses you must wait at least 10 to 15 minutes after instilling Lotemax before inserting your contact lenses.
- Your doctor will tell you how long your treatment with Lotemax eye drops will last.
- If redness or itching become aggravated consult your doctor.
- If you are using another medicine in the eye, wait at least 10 minutes before applying.
- Lotemax should be stored upright between 15°–25°C for up to 28 days after first opening.
If you use more Lotemax than you should, or there is accidental oral ingestion, you should immediately contact your doctor, or regional poison control centre.
If you forget to use Lotemax eye drops, wait until the next dose and then continue as before. Do not double doses.
Side Effects and what to do about them
Eye drops can cause your vision to be blurred. This usually passes quickly. Do not drive or use machines until your vision is clear. Like all medicines, Lotemax can have unwanted effects. The most common side effects in patients treated with Lotemax are:
- Increased pressure within the eye
- Blurred or abnormal vision
- Burning when putting drops in the eye or at any time while on the medication
- Swelling or discharge from the eyes
- Painful, dry or sticky eyes
- Sensation of having an object in your eye
- Itching in the eye or on the eyelid
- Redness in the eye or on the eyelid
- Photophobia (discomfort on exposure to light)
Other unwanted effects might include:
- Headache or migraine, cough or sore throat, runny nose, fatigue, nervousness, facial swelling, general pain, or rash.
If you notice these or any other effects, tell your doctor or a pharmacist.
This is not a complete list of side effects. For any unexpected effects while taking Lotemax, contact your doctor or pharmacist.
How to store it
Store upright between 15°–25°C (59°–77°F). DO NOT FREEZE.
Keep out of reach of children.
Reporting Suspected Side Effects
To monitor drug safety, Health Canada through the Canada Vigilance Program collects information on serious and unexpected effects of drugs . If you suspect you have had a serious or unexpected reaction to this drug you may notify Canada Vigilance:
toll-free telephone: 866-234-2345
toll-free fax 866-678-6789
By email: CanadaVigilance@hc-sc.gc.ca
By regular mail:
Canada Vigilance National Office
Marketed Health Products Safety and Effectiveness
Marketed Health Products Directorate
Health Products and Food Branch
Tunney❜s Pasture, AL 0701C
Ottawa ON K1A 0K9
NOTE: Should you require information related to the management of the side effect, please contact your health care provider before notifying Canada Vigilance. The Canada Vigilance Program does not provide medical advice.
This document plus the full product monograph, prepared for health professionals can be found at:
or by contacting the sponsor, Bausch & Lomb Incorporated, at: